272 related articles for article (PubMed ID: 9809686)
1. What should men know about prostate-specific antigen screening before giving informed consent?
Chan EC; Sulmasy DP
Am J Med; 1998 Oct; 105(4):266-74. PubMed ID: 9809686
[TBL] [Abstract][Full Text] [Related]
2. Informed consent for cancer screening with prostate-specific antigen: how well are men getting the message?
Chan EC; Vernon SW; O'Donnell FT; Ahn C; Greisinger A; Aga DW
Am J Public Health; 2003 May; 93(5):779-85. PubMed ID: 12721144
[TBL] [Abstract][Full Text] [Related]
3. A structured implicit abstraction method to evaluate whether content of counseling before prostate cancer screening is consistent with recommendations by experts.
Farrell MH; Chan EC; Ladouceur LK; Stein JM
Patient Educ Couns; 2009 Dec; 77(3):322-7. PubMed ID: 19837527
[TBL] [Abstract][Full Text] [Related]
4. The impact of informed consent on patient interest in prostate-specific antigen screening.
Wolf AM; Nasser JF; Wolf AM; Schorling JB
Arch Intern Med; 1996 Jun; 156(12):1333-6. PubMed ID: 8651843
[TBL] [Abstract][Full Text] [Related]
5. Physician perspectives on the importance of facts men ought to know about prostate-specific antigen testing.
Chan EC; Vernon SW; Haynes MC; O'Donnell FT; Ahn C
J Gen Intern Med; 2003 May; 18(5):350-6. PubMed ID: 12795733
[TBL] [Abstract][Full Text] [Related]
6. Prostate cancer screening and beliefs about treatment efficacy: a national survey of primary care physicians and urologists.
Fowler FJ; Bin L; Collins MM; Roberts RG; Oesterling JE; Wasson JH; Barry MJ
Am J Med; 1998 Jun; 104(6):526-32. PubMed ID: 9674714
[TBL] [Abstract][Full Text] [Related]
7. Screening for prostate cancer. How can patients give informed consent?
Marshall KG
Can Fam Physician; 1993 Nov; 39():2385-90. PubMed ID: 7505673
[TBL] [Abstract][Full Text] [Related]
8. Screening for prostate cancer with the prostate-specific antigen test: are patients making informed decisions?
O'Dell KJ; Volk RJ; Cass AR; Spann SJ
J Fam Pract; 1999 Sep; 48(9):682-8. PubMed ID: 10498074
[TBL] [Abstract][Full Text] [Related]
9. The importance of patient preference in the decision to screen for prostate cancer. Prostate Patient Outcomes Research Team.
Flood AB; Wennberg JE; Nease RF; Fowler FJ; Ding J; Hynes LM
J Gen Intern Med; 1996 Jun; 11(6):342-9. PubMed ID: 8803740
[TBL] [Abstract][Full Text] [Related]
10. Do Men Receive Information Required for Shared Decision Making About PSA Testing? Results from a National Survey.
Leyva B; Persoskie A; Ottenbacher A; Hamilton JG; Allen JD; Kobrin SC; Taplin SH
J Cancer Educ; 2016 Dec; 31(4):693-701. PubMed ID: 26498649
[TBL] [Abstract][Full Text] [Related]
11. Cultural sensitivity and informed decision making about prostate cancer screening.
Chan EC; Haynes MC; O'Donnell FT; Bachino C; Vernon SW
J Community Health; 2003 Dec; 28(6):393-405. PubMed ID: 14620963
[TBL] [Abstract][Full Text] [Related]
12. Deliberative democracy and cancer screening consent: a randomised control trial of the effect of a community jury on men's knowledge about and intentions to participate in PSA screening.
Thomas R; Glasziou P; Rychetnik L; Mackenzie G; Gardiner R; Doust J
BMJ Open; 2014 Dec; 4(12):e005691. PubMed ID: 25539779
[TBL] [Abstract][Full Text] [Related]
13. PSA testing for men at average risk of prostate cancer.
Armstrong BK; Barry MJ; Frydenberg M; Gardiner RA; Haines I; Carter SM
Public Health Res Pract; 2017 Jul; 27(3):. PubMed ID: 28765854
[TBL] [Abstract][Full Text] [Related]
14. Screening for prostate cancer: a guidance statement from the Clinical Guidelines Committee of the American College of Physicians.
Qaseem A; Barry MJ; Denberg TD; Owens DK; Shekelle P;
Ann Intern Med; 2013 May; 158(10):761-769. PubMed ID: 23567643
[TBL] [Abstract][Full Text] [Related]
15. Prostate-specific antigen testing in Ontario: reasons for testing patients without diagnosed prostate cancer.
Bunting PS; Goel V; Williams JI; Iscoe NA
CMAJ; 1999 Jan; 160(1):70-5. PubMed ID: 9934349
[TBL] [Abstract][Full Text] [Related]
16. Consent before testing men for prostate cancer--a challenge?
Hirst G
Aust Fam Physician; 2005 Oct; 34(10):888. PubMed ID: 16217582
[No Abstract] [Full Text] [Related]
17. National trends in prostate cancer screening among older American men with limited 9-year life expectancies: evidence of an increased need for shared decision making.
Drazer MW; Prasad SM; Huo D; Schonberg MA; Dale W; Szmulewitz RZ; Eggener SE
Cancer; 2014 May; 120(10):1491-8. PubMed ID: 24523016
[TBL] [Abstract][Full Text] [Related]
18. The prostate cancer pseudo-epidemic.
Adami HO
Acta Oncol; 2010 Apr; 49(3):298-304. PubMed ID: 20397765
[TBL] [Abstract][Full Text] [Related]
19. Informed decision making on PSA testing for the detection of prostate cancer: an evaluation of a leaflet with risk indicator.
van Vugt HA; Roobol MJ; Venderbos LD; Joosten-van Zwanenburg E; Essink-Bot ML; Steyerberg EW; Bangma CH; Korfage IJ
Eur J Cancer; 2010 Feb; 46(3):669-77. PubMed ID: 20022239
[TBL] [Abstract][Full Text] [Related]
20. Exploring the complexities of prostate cancer screening with a view to supporting informed consent.
Laws TA
Contemp Nurse; 2004 Oct; 17(3):223-30. PubMed ID: 15551673
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]